Article
Pyridoxine-dependent Epilepsy caused by a Novel homozygous mutation in PLPBP Gene.
Metabolic brain disease - 1 Dec 2022
İpek Rojan, Çavdartepe Büşra Eser, Kor Deniz, Okuyaz Çetin
Abstract excerpt
Seizures in newborn infants may be the first finding of hereditary metabolic diseases. Pyridoxine-dependent epilepsy (PDE) is a treatable disorder associated with defects in the one of ALDH7A1, PNPO, or PLPBP genes and it is uncommon but progresses with persistent seizures in the neonatal and infancy period. The seizures are generally resistant to traditional antiepileptic drugs and show a dramatic response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
